Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease

被引:56
作者
Aucoin, JS
Jiang, P
Aznavour, N
Tong, XK
Buttini, M
Descarries, L
Hamel, E
机构
[1] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada
[2] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada
[4] Univ Montreal, Ctr Rech Sci Neurol, Fac Med, Montreal, PQ H3C 3J7, Canada
[5] Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA
基金
新加坡国家研究基金会;
关键词
amyloid precursor protein (APP); acetylcholine; inflammation; amyloid; manganese SOD; neurodegeneration;
D O I
10.1016/j.neuroscience.2004.11.047
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is characterized by increases in amyloid-beta (AP) peptides, neurofibrillary tangles, oxidative stress and cholinergic deficits. However, the selectivity of these deficits and their relation with the AP pathology or oxidative stress remain unclear. We therefore investigated amyloidosis-related changes in acetylcholine (ACh) and serotonin (5-HT) innervations of hippocampus and parietal cortex by quantitative choline acetyltransferase (ChAT) and 5-HT immunocytochemistry, in 6,12/14 and 18 month-old transgenic mice carrying familial AD-linked mutations (hAPP(Sw,Ind)). Further, using manganese superoxide dismutase (MnSOD) and nitrotyrosine immunoreactivity as markers, we evaluated the relationship between oxidative stress and the ACh deficit in 18 month-old mice. Thioflavin-positive AP plaques were seen in both regions at all ages; they were more numerous in hippocampus and increased in number (> 15-fold) and size as a function of age. A majority of plaques exhibited or were surrounded by increased MnSOD immunoreactivity, and dystrophic ACh or 5-HT axons were seen in their immediate vicinity. Counts of immunoreactive axon varicosities revealed significant decreases in ACh innervation, with a sparing of the 5-HT, even in aged mice. First apparent in hippocampus, the loss of ACh terminals was in the order of 20% at 12/14 months, and not significantly greater (26%) at 18 months. In parietal cortex, the ACh denervation was significant at 18 months only, averaging 24% across the different layers. Despite increased perivascular MnSOD immunoreactivity, there was no evidence of dystrophic ACh varicosities or their accentuated loss in the perivascular area. Moreover, there was virtually no sign of tyrosine nitration in ChAT nerve terminals or neuronal cell bodies. These data suggest that aggregated AP exerts an early, non-selective and focal neurotoxic effect on both ACh and 5-HT axons, but that a selective, plaque- and oxidative stress-independent diffuse cholinotoxicity, most likely caused by soluble AP assemblies, is responsible for the hippocampal and cortical ACh denervation. (c) 2005 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 86
页数:14
相关论文
共 90 条
[1]  
Allen DD, 1997, NEUROSCI LETT, V234, P71
[2]   Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor protein [J].
Apelt, J ;
Kumar, A ;
Schliebs, R .
BRAIN RESEARCH, 2002, 953 (1-2) :17-30
[3]   Alzheimer's disease and the basal forebrain cholinergic system:: relations to β-amyloid peptides, cognition, and treatment strategies [J].
Auld, DS ;
Kornecook, TJ ;
Bastianetto, S ;
Quirion, R .
PROGRESS IN NEUROBIOLOGY, 2002, 68 (03) :209-245
[4]   Comparative analysis of cholinergic innervation in the dorsal hippocampus of adult mouse and rat: A quantitative immunocytochemical study [J].
Aznavour, N ;
Mechawar, N ;
Descarries, L .
HIPPOCAMPUS, 2002, 12 (02) :206-217
[5]  
AZNAVOUR N, 2003, NEUROTOXICITY BETA A
[6]   The cholinergic deficit coincides with Aβ deposition at the earliest histopathologic stages of Alzheimer disease [J].
Beach, TG ;
Kuo, YM ;
Spiegel, K ;
Emmerling, MR ;
Sue, LI ;
Kokjohn, K ;
Roher, AE .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (04) :308-313
[7]  
BIERER LM, 1995, J NEUROCHEM, V64, P749
[8]   Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis [J].
Boncristiano, S ;
Calhoun, ME ;
Kelly, PH ;
Pfeifer, M ;
Bondolfi, L ;
Stadler, M ;
Phinney, AL ;
Abramowski, D ;
Sturchler-Pierrat, C ;
Enz, A ;
Sommer, B ;
Staufenbiel, M ;
Jucker, M .
JOURNAL OF NEUROSCIENCE, 2002, 22 (08) :3234-3243
[9]   Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein London mutant transgenic mice [J].
Bronfman, FC ;
Moechars, D ;
Van Leuven, F .
NEUROBIOLOGY OF DISEASE, 2000, 7 (03) :152-168
[10]   Role of serotonin in memory impairment [J].
Buhot, HC ;
Martin, S ;
Segu, L .
ANNALS OF MEDICINE, 2000, 32 (03) :210-221